Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Long-term Safety of TAK-881 (Human Normal Immunoglobulin, Hyaluronidase) for Patients with Primary Immunodeficiency Diseases

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Czechia Denmark Germany Greece The Netherlands Poland +2
  • Study on the Safety and Effects of INZ-701 for Infants with ENPP1 or ABCC6 Deficiency

    Not recruiting

    1 1 1
    Spain
  • Study on Vericiguat for Children with Heart Failure from Left Ventricular Systolic Dysfunction

    Not recruiting

    3 1 1
    Investigated Drugs:
    Belgium Denmark Finland France Germany Hungary +7
  • Study of SAR443579 Infusion for Adults and Children with Relapsed or Refractory Acute Myeloid Leukemia, B-Cell Acute Lymphoblastic Leukemia, HR-MDS, or BPDCN

    Not recruiting

    2 1 1 1
    France The Netherlands
  • Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma

    Not recruiting

    3 1 1
    Investigated Diseases:
    Czechia Germany Greece Portugal Slovakia
  • Safety Study of Damoctocog Alfa Pegol for Children Aged 7 to 11 with Severe Hemophilia A

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Italy Norway
  • Study of erdafitinib treatment for adults and adolescents with advanced solid tumors having FGFR gene changes

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Spain
  • Study on the Safety and Immune Response of V116 Vaccine in Children and Adolescents at Higher Risk for Pneumococcal Disease

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Finland France Poland Spain Sweden
  • Study of Belimumab for Children with Systemic Lupus Erythematosus (SLE)

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Spain
  • Study on the Effectiveness and Safety of Infigratinib for Children Aged 3 to 17 with Achondroplasia

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Norway Spain